On the 12th of September, SAHPRA confirmed the second death from "rare syndrome" linked to Covid-19 vaccination. Guillain-Barre’ Syndrome (GBS) is the name of this "rare syndrome". Guillain-Barré syndrome (GBS) is a neurological disorder in which the body's immune system mistakenly attacks part of its peripheral nervous system—the network of nerves located outside of the brain and spinal cord. GBS can range from a very mild case with brief weakness to nearly devastating paralysis, leaving the person unable to breathe independently. Fortunately, most people eventually recover from even the most severe cases of GBS. After recovery, some people will continue to have some degree of weakness. The original description of "ascending paralysis" encompasses the most common variety and is the hallmark of GBS paralysis. People with GBS can have difficulty walking, seeing, swallowing, speaking and chewing. Likewise, GBS can result in severe muscle pain, lack of coordination, heart and blood pressure abnormalities, digestive problems and incontinence. Often, the symptoms worsen over a period of a few days up to a few weeks, with the worst effects typically occurring about four weeks into the syndrome. GuillainBarré Syndrome can affect anyone. It can strike at any age (although it is more frequent in adults and older people), and both sexes are equally prone to the disorder. The National Institute of Neurological Disorders and Strokes estimates that GBS affects about one person in 100,000 each year, thus making it a "rare" condition. "SARS-CoV-2 vaccinations are not free from side effects. Usually, they are mild or moderate, but occasionally they are severe. One of these severe side effects is Guillain-Barré syndrome (GBS). This review summarizes and discusses GBS as a side effect of SARS-CoV-2 vaccinations (SCoVaG) based on recent research reports. Altogether, nine articles reporting 18 patients with SCoVaG were identified, and one more report on another patient is under review. In all 19 patients, SCoVaG developed after the first dose of the vaccine. The Astra Zeneca vaccine was used in fourteen patients, the Pfizer vaccine in four patients, and the Johnson & Johnson vaccine was applied to one patient. Only a single patient recovered completely, and partial recovery was achieved in nine patients. In conclusion, GBS may develop time-linked to the first dose of a SARS-CoV-2 vaccination. Though a causal relationship between SARS-CoV-2 vaccinations and SCoVaG remains speculative, more evidence is in favour than against it." Finsterer et al explain in a PubMed abstract (Oct 2021) That's 19 people "affected" with GBS post-jab. In less than 6 weeks, South Africa alone has seen 2 deaths post Covid-19 "vaccination" from GBS. Still think this is rare? Especially since these are just the 2 deaths that SAHPRA (alone) has confirmed (so far) as to have been caused by the jab.I did a quick search for any association between GBS post jab. Within minutes, I found several. A Korean study discussed 19 cases of GBS post C-19 Jab https://pubmed.ncbi.nlm.nih.gov/34644738/. A study by Tabatabaee et al was about three cases of GBS post C-19 jab. https://pubmed.ncbi.nlm.nih.gov/35240922/. There were 51 documented cases post C-19 jab in The GMS article "COVID-19 and the Unraveling of Experimental Medicine - Part Ill". A CDC study shows the risk of Guillain-Barré syndrome is elevated after Ad.26.COV2.S COVID (adenovirus vector vaccines like J&J and Astra-Zeneca) vaccination. https://www.newsmedical.net/news/20211208/CDC-study-shows-risk-ofGuillain-Barre-syndrome-elevated-after-Ad26COV2SCOVID-vaccination.aspx. I did not need any more convincing. If GBS was a rare condition before the jab rollout, that is no longer the case. The exact cause of GBS is not known. Researchers don’t know why it strikes some people and not others. It is not contagious or inherited. What they do know is that the affected person's immune system begins to attack the body itself. It is thought that, at least in some cases, this immune attack is initiated to fight an infection and that some chemicals on infecting bacteria and viruses resemble those on nerve cells, which, in turn, also become targets of attack. Since the body’s own immune system does the damage, GBS is called an autoimmune disease ("auto" meaning "self"). Normally the immune system uses antibodies (molecules produced in an immune response) and special white blood cells to protect us by attacking infecting microorganisms (bacteria and viruses). In Guillain-Barré syndrome, however, the immune system mistakenly attacks the healthy nerves. Many experts have warned of "toxins" in the jabs. The ingredients in the shots have been listed by the manufacturers themselves. No analysis by independent panels have been recognised. Geert Vanden Bossche and other experts have warned of VAIDS (Vaccine Acquired Immune Deficiency Syndrome). The increase in GBS post jab roll out proves this theory. It's difficult to ascertain how many GBS cases have been reported in South Africa post jab roll-out. How many deaths have occurred from GBS in "vaccinated" persons remains a mystery at this time. It is not a requirement to note vaccination status on death certificates. I’m certain eyes will r
oll, heads will turn and law suits will abound if it becomes compulsory to note the vaccination status when certifying deaths. Strange how it was compulsory to do a Covid test on all those who died during the pandemic (even those who died in car accidents), and yet post experimental, emergency use authorisation roll out of gene therapy shots, its a glaring omission. We all know why …